New York, NY
,
USA
·
North America
Casdin Capital is a New York-based investment firm focused on the life sciences sector, with a conviction that transformative medicines represent exceptional investment opportunities. The firm invests $5M–$30M across Series A through late-stage biotechnology and genomics companies. Portfolio companies include 10x Genomics, Absci, Akeso, and BioNTech.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
